Recent studies have proved, from several documented cases that vaping helped resolved chronic respiratory bacterial infections
In 2017, Peter Hajek and Joanna Miler published a paper, “chronic tonsillitis resolution in an individual with no smoking history who became a vaper. A case study and new hypothesis” where an individual without any history of smoking who suffered chronic tonsillitis experienced significant improvements after some periods of vaping.
According to the researchers; “we have recently reported and documented a correlation between chronic throat infection resolution and vaping in an individual with no smoking history. There are two humectants utilized by E-cigarette liquids; vegetable glycerol and propylene glycol (PG). The observed vaping effect could be as a result of virucidal and bactericidal properties exerted by the PG.
Vaping resolved two different chronic infections types
A doctor with similar results has been in contact with the researchers following this publication. They have this to say; “Consequent to this report, a medical doctor with no history of smoking has reported cases of chronic nasal infection resolution due to the use of e-liquid with vegetable glycol as the only content.”
Another paper with title: “Chronic nasal Staphylococcus aureus infection resolution in a non-smoker who adopted the use of glycerine-based e-cigarettes: Could this be Vaping Antibacterial effects?” also reported a case of complete nasal Staphylococcus aureus infection resolution in an individual with no smoking history after some weeks of using his wife’s e-cigarette which contained vegetable glycerine with low nicotine levels (3 mg/ml).
Some compounds in e-liquids may have antimicrobial properties
According to the duo, Hajek, and Miler, this infection resolution could be as a result of the properties of the compounds found in the vaping product, though there are still possibilities of mere coincidence.
In a statement; “there is no way that such improvements would be attributed to bacterial effect of PG or smoking cessation. There could be a trace to the antimicrobial effects of nicotine and/or nicotine complex or the bacteriostatic effects of glycerol”
The researchers concluded by saying that “using nicotine levels and humectants to assess the effects of e-cigarettes in patients with chronic respiratory infections could provide more clarity to this problem and provide a clue to treatment options”.